ArticleThe Journal of clinical investigation2026
LINGO1-targeted antibody-drug conjugates improve efficacy and tolerability of antineoplastic therapies in Ewing sarcoma models.
Zhichuan Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.